coronavirus vaccine

Stories 761 - 780 | << Prev   Next >>

Moderna Reports Great News on Its Vaccine

Early results suggest it's nearly 95% effective

(Newser) - A week ago, Pfizer reported excellent early results on its COVID vaccine. Now, a second major contender also is reporting data, and the results are even better. Moderna announced Monday that preliminary results suggest its coronavirus vaccine is 94.5% effective, reports Reuters . Pfizer's figure was 90%. The upshot...

Biden People Reach Out to Vaccine Manufacturers

'It would be better if we could start working with them'

(Newser) - Joe Biden's scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Trump's refusal to acknowledge that he lost the election, the AP reports. That delayed handoff is especially problematic during a public health crisis, the government's top...

Fauci Sets Possible Date for Return to &#39;Normal&#39;
Fauci Sets
Possible Date
for Return
to 'Normal'
sunday talk shows
Nov 15, 2020 12:30 PM CST

Fauci Sets Possible Date for Return to 'Normal'

And more around the Sunday dial

(Newser) - Anthony Fauci is talking like he's caught a glimpse of the end of the pandemic tunnel, CNN reports. The infectious-disease expert said Sunday on State of the Union that America might start getting back to "relative normal" by as early as April 2021—if, that is, the newly...

Trump: When Vaccine Is Ready for US, NY Won't Get It at First

Gov. Andrew Cuomo, NY AG Letitia James push back on president's inflammatory remarks

(Newser) - On Friday, President Trump gave his first public remarks since losing the election to Joe Biden, speaking at the White House about the need for Americans to remain "vigilant" against COVID-19, and how a vaccine would soon be on its way. One statement about the vaccine, however, raised eyebrows,...

Trump Resurfaces to Tout Vaccine
Trump
Emerges
to Tout
Vaccine
UPDATED
Nov 13, 2020 5:19 PM CST

Trump Emerges to Tout Vaccine

Rose Garden comments don't include a concession to Biden

(Newser) - Gliding over significant challenges still to come, President Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. Trump still did not concede the election, and he did not...

Market Ends Week the Way It Started
Market Ends Week
the Way It Started
MARKETS
Nov 13, 2020 3:10 PM CST

Market Ends Week the Way It Started

Dow rises 399, with the week's positive vaccine news getting the credit

(Newser) - The stock market capped a strong week with a strong finish on Friday. The Dow rose 399 points, or 1.3%, to 29,479, while the S&P 500 rose 48 points, or 1.3%, to 3,585, and the Nasdaq rose 119 points, or 1%, to 11,829. Generally,...

Ticketmaster Has Idea on How to Restart Concerts

Vetting of vaccinated or negative status could be linked to digital ticket

(Newser) - In the 2011 movie Contagion, wristbands were used to identify vaccinated people during a pandemic. Ticketmaster's plan is a little more complicated, but with Pfizer's coronavirus vaccine candidate showing promising results, the company hopes it will get fans back to concerts and sporting events at some point next...

Pfizer CEO Sold Big Chunk of Shares on Day of Vaccine News

He sold $5.6M in shares as price soared

(Newser) - Pfizer CEO Albert Bourla sold a big chunk of his shares on the same day the company announced very promising news on a coronavirus vaccine , according to an SEC filing. Bourla sold shares worth $5.6 million as the company's stock price soared on Monday, but the company says...

Russia: Our Sputnik V Vaccine Works
Russia:
Our Sputnik V
Vaccine Works
Nov 11, 2020 8:38 AM CST

Russia: Our Sputnik V Vaccine Works

Says it shows 92% efficacy against the coronavirus

(Newser) - In a dramatic first among nations , Russia approved its Sputnik V coronavirus vaccine in August. Two months later, the country is sharing data that it says points to the vaccine's effectiveness. The Wall Street Journal reports interim results from the 40,000-person Phase 3 trial that is underway have...

Brazil Halts Vaccine Trial After 'Serious Incident'

Bolsonaro calls CoronaVac move a 'victory'

(Newser) - Brazil's health regulator has halted clinical trials of the potential coronavirus vaccine CoronaVac, citing an "adverse, serious event." Adversaries of President Jair Bolsonaro said they feared the decision was motivated not by science but by the leader's political hostility to the country and state involved in...

What Fauci Thinks About Pfizer Vaccine

'Extraordinary,' he says, and explains why the news is doubly good

(Newser) - Anthony Fauci isn't mincing words when it comes to the coronavirus vaccine Pfizer has on the horizon . "The results are really quite good, I mean extraordinary," said the director of the National Institute of Allergy and Infectious Diseases. He added that that might also be good news...

&#39;Dream Team&#39; Couple Are Behind New Vaccine
'Dream Team' Couple Helped
Develop New Vaccine
THE RUNDOWN
Nov 9, 2020 3:23 PM CST

'Dream Team' Couple Helped Develop New Vaccine

Huge challenges will await after approval

(Newser) - The exhilarating news that a COVID-19 vaccine was a big success in a large-scale trial is a victory for Pfizer—and for the husband-and-wife team behind BioNTech, the German biotech firm that collaborated with the American drugmaker. CEO Ugur Sahin and his wife, board member Oezlem Tuereci, founded the firm...

Donald Trump Jr. Thinks Vaccine News Is a Little Fishy

He suggests Pfizer delayed news to benefit Joe Biden

(Newser) - Pfizer's announcement that its vaccine appears to deliver strong protection against COVID-19 was hailed as great news in the stock market and beyond. But Donald Trump Jr. sees a political conspiracy at play, suggesting that the company held off on the news to hurt his father's reelection chances,...

Dow Smashes Record, but Zoom Is Hurting

All this after Pfizer reported hopeful news on a vaccine

(Newser) - The futures traders were right : The Dow came out of the gate on fire Monday, soaring more than 1,500 points at the open to an all-time high, reports CNBC . The great start comes after Pfizer announced that its COVID vaccine looks to be 90% effective in early results. At...

Pfizer Reports Big News on Early Vaccine Results

Preliminary data shows it's 90% effective

(Newser) - Pfizer says early data suggest its COVID vaccine works—in a big way. The company said Monday that its vaccine appears to be 90% effective in preventing infections, without serious side effects, reports the New York Times . A big qualification: These are early results, and the numbers could drop as...

Feds Scrap Plan for Santa to Promote Vaccine

Santas, helpers would have received vaccine early

(Newser) - Santa and his helpers will no longer be among the first in line for a coronavirus vaccine. The Department of Health and Human Services has scrapped a plan to have Santa Clauses in dozens of cities promote the benefits of vaccination in return for early access to a vaccine, the...

Vaccine Candidate Has Good News for Seniors

Candidate from AstraZeneca and Oxford sees immune response, few side effects in older adults

(Newser) - Bad news about COVID is easy to find these days, whether in the US or overseas . But now comes a dose of good news from the makers of one of the leading vaccine candidates. AstraZeneca, which is teaming with Oxford University, said Monday that its vaccine produces an immune response...

New COVID Trials Will Be 'a Little Different From Most'

'Human challenge' studies in the UK will involve deliberately injecting healthy subjects with virus

(Newser) - Clinical trials for a COVID-19 vaccine are currently in their final stages via a number of drug companies, but a new set soon to begin in the UK promises to be "a little different from most." CNN reports the British government has signed a contract for the first...

Pfizer's Update on Vaccine Is a 'Shift in Tone'

Announcement on application for emergency authorization predicts late November at the earliest

(Newser) - Last month, President Trump hinted that a COVID-19 vaccine could be available before Election Day, but the latest news from one of the leading developers seems to make that possibility even more remote. As the Wall Street Journal reports, Pfizer CEO Albert Bourla posted an open letter Friday announcing that,...

&#39;Gloomy&#39; Pandemic Reporter: I Can Finally See Hope
'Gloomy' COVID Reporter
Has a Change of Heart 
OPINION
Oct 13, 2020 11:42 AM CDT

'Gloomy' COVID Reporter Has a Change of Heart

Donald G. McNeil Jr. is 'cautiously optimistic' about what lies ahead

(Newser) - Since January, New York Times health reporter Donald G. McNeil Jr. has been covering the pandemic, including American deaths and efforts to develop a vaccine years ahead of the fastest pace on record. All this has made him "a consistently gloomy Cassandra"—but halfway through October, he's...

Stories 761 - 780 | << Prev   Next >>
Most Read on Newser